Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein.
about
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread.Two-step conformational changes in a coronavirus envelope glycoprotein mediated by receptor binding and proteolysisIdentification of N-linked carbohydrates from severe acute respiratory syndrome (SARS) spike glycoprotein.Characterization of Lassa virus glycoprotein oligomerization and influence of cholesterol on virus replication.A single tyrosine in the severe acute respiratory syndrome coronavirus membrane protein cytoplasmic tail is important for efficient interaction with spike proteinStructure, Function, and Evolution of Coronavirus Spike Proteins.Functional characterization of heptad repeat 1 and 2 mutants of the spike protein of severe acute respiratory syndrome coronavirus.Conformational states of the severe acute respiratory syndrome coronavirus spike protein ectodomain.Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron cryomicroscopy.Membrane-Active Sequences within gp41 Membrane Proximal External Region (MPER) Modulate MPER-Containing Peptidyl Fusion Inhibitor Activity and the Biosynthesis of HIV-1 Structural ProteinsThe cytoplasmic tail of the severe acute respiratory syndrome coronavirus spike protein contains a novel endoplasmic reticulum retrieval signal that binds COPI and promotes interaction with membrane protein.Lack of interference with immunogenicity of a chimeric alphavirus replicon particle-based influenza vaccine by preexisting antivector immunityHosting the severe acute respiratory syndrome coronavirus: specific cell factors required for infection.SARS-coronavirus spike S2 domain flanked by cysteine residues C822 and C833 is important for activation of membrane fusion.Immunogenicity and protection efficacy of monomeric and trimeric recombinant SARS coronavirus spike protein subunit vaccine candidatesVaccines to prevent severe acute respiratory syndrome coronavirus-induced disease.Entry from the cell surface of severe acute respiratory syndrome coronavirus with cleaved S protein as revealed by pseudotype virus bearing cleaved S protein.Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sitesSARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-kappaB pathway in human monocyte macrophages in vitro.Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide.Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropismSpike protein, S, of human coronavirus HKU1: role in viral life cycle and application in antibody detection.Important role for the transmembrane domain of severe acute respiratory syndrome coronavirus spike protein during entry.Adenovirus-mediated expression of the C-terminal domain of SARS-CoV spike protein is sufficient to induce apoptosis in Vero E6 cells.Architecture of the SARS coronavirus prefusion spike.GxxxG motif of severe acute respiratory syndrome coronavirus spike glycoprotein transmembrane domain is not involved in trimerization and is not important for entry.SARS vaccine protective in mice.Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2
P2860
Q24815979-E9991778-EA8F-4C1E-92B7-624C4DDA75E0Q30436297-14A70E1A-C216-4739-A67F-98768C8637B4Q33529338-6BCAE05D-918A-411C-B114-FB0AAE6D3480Q33558319-DDCA71CA-F1C0-4356-8E2C-5EE231AA2F58Q33614610-DC971329-2CD7-402F-A6EE-F7E384AF8817Q33760875-23A666C5-4543-4515-B949-410B3683CF4AQ34545772-708D1850-8210-4D37-B26F-8B3FCBE6AF42Q34717693-16329701-84C7-4590-BE9F-28C1678C85F1Q35024038-91395E8D-6153-45B4-9372-EDB04AE929A3Q35729956-29198943-2037-48A1-AA47-7B1AAB9442E8Q35784645-13394BB3-6BE1-4F46-B605-6741B7A1D761Q36086236-0BF96184-4E42-4A49-A29E-B778A57723BEQ36520754-BA629541-F353-4EA9-81C9-E685CB411FA4Q36676297-4D4C9F95-6678-4336-A3A9-0451315D010CQ36760764-C9BD5584-8BE0-4FF3-A372-0E5D2779FED4Q36784740-6DA954A0-00C0-469E-A7E7-7CA0F601FF5FQ36974675-DAC989F8-A611-4B45-9DFA-65FD10328EE6Q37138587-E0653FAB-76A1-454F-ACA2-554C92328987Q37234254-E86DF021-D9F5-447C-AC4E-23164ED4A041Q37256710-F844CA45-3853-4EE3-B905-C89CADA53E0DQ37379647-0BD0B6C6-5A3E-466C-8F6C-43C56BC84F19Q39930184-54346BE3-C4BB-4B95-825C-EA5D0F5D6246Q40329154-3E496D82-FD96-455D-8DB8-27890F15CAFDQ40347096-96321F1F-E753-482F-966A-F5916EC50037Q41625896-F59AAC2A-43D6-4F2F-9930-2F2316E607DAQ42261414-C7758FA7-4178-4334-8E6D-7F089F8287EFQ42555546-310E642E-5C90-4073-9E7A-25C99BE4C05CQ58785257-D7C9EFF5-8FAC-4142-8FBC-3D707E374D83
P2860
Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Synthesis and characterization ...... oronavirus spike glycoprotein.
@en
Synthesis and characterization ...... oronavirus spike glycoprotein.
@nl
type
label
Synthesis and characterization ...... oronavirus spike glycoprotein.
@en
Synthesis and characterization ...... oronavirus spike glycoprotein.
@nl
prefLabel
Synthesis and characterization ...... oronavirus spike glycoprotein.
@en
Synthesis and characterization ...... oronavirus spike glycoprotein.
@nl
P2093
P2860
P50
P921
P1433
P1476
Synthesis and characterization ...... oronavirus spike glycoprotein.
@en
P2093
Byoung J Yoo
Catherine E Greer
Hyun Chul Song
Jang H Han
John M Polo
Konrad Stadler
Markus Eickmann
Mi-Young Seo
Michael Houghton
Qui-Lim Choo
P2860
P304
10328-10335
P356
10.1128/JVI.78.19.10328-10335.2004
P407
P577
2004-10-01T00:00:00Z